Translational Research Pilot Awards T1/T2 – Early Stage Clinical Testing
Scope of Proposals
This funding opportunity is for projects in the T1 or T2 stage of translational research (For further information on the T stages of research, see Blumberg et al. Nat Med 18: 35-41). T1/T2 phases of translational research move laboratory or preclinical discoveries into health practice by determining safety, efficacy, or performance of the discoveries in humans. Projects must involve human participation, as opposed to laboratory studies on mechanism discovery or pathophysiology.
T1 is described as research that yields knowledge about new methods of diagnosis, treatment and prevention. Pilot T1 studies might test whether interventions derived from basic research can produce effects in humans.
T2 is described as research that yields knowledge about the efficacy of interventions in optimal settings. Pilot T2 projects might test the feasibility of a controlled clinical trial or gather information essential to the design of a trial.
Examples of projects that might fit this opportunity would include
Maximum Award Requests:
Pilot awards may request up to $25,000 direct costs for one year. No indirect support will be provided.
|April 7, 2017||Round 1 Applications Due by 11:59 p.m.|
|April 24, 2017||Notification of Round 1 Selection|
|May 12, 2017||Round 2 Application Due by 11:59 p.m.|
|May 31, 2017||Application Review Completed|
|August 2017||Funding Begins*|
*Exact date may vary. Funds stem from an institutional award made by the National Center for Advancing Translational Sciences (NCATS). Federal policy requires that the project may not commence until a representative from NCATS has administratively approved the pilot projects selected by CTSI. The NCATS approval process cannot commence until required approvals (IRB, IACUC, hSCRO, IBC, CORID, etc.) are obtained. NCATS approval will likely take at least four weeks.